Cytosorbents CorporationCTSONASDAQ
Loading
ROIC: Strong ReturnsExpanding
Percentile Rank79
Studio
Year-over-Year Change

Return on invested capital

Latest
-40.84%
↑ 47% vs avg
Percentile
P79
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-76.40%
Historical baseline
PeriodValueYoY Change
2024-40.84%+45.4%
2023-74.74%-31.4%
2022-56.89%-96.8%
2021-28.90%-155.8%
2020-11.30%+87.4%
2019-89.92%-62.9%
2018-55.20%-22.7%
2017-44.99%+82.2%
2016-252.24%-131.5%
2015-108.96%-